-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Adma Biologics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2011 to Q4 2024.
- Adma Biologics, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was $38.3M, a 169% increase year-over-year.
- Adma Biologics, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was $139M, a 542% increase year-over-year.
- Adma Biologics, Inc. annual Operating Income (Loss) for 2024 was $139M, a 542% increase from 2023.
- Adma Biologics, Inc. annual Operating Income (Loss) for 2023 was $21.6M.
- Adma Biologics, Inc. annual Operating Income (Loss) for 2022 was -$39.4M, a 32.6% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)